Relationship between interleukin-6 (IL-6) levels and chest X-ray severity scoring in COVID-19 patients
Narra J · 2024
DOI: 10.52225/narra.v4i1.690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Narra J, 2024. Verfasst von Alzi Kardiasyah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Interleukin-6, Severity of Illness Index, Radiography, Thoracic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The severity of coronavirus disease 2019 (COVID-19) may be measured by interleukin-6 (IL-6) and chest X-rays. Brixia score of the chest radiographs is usually used to monitor COVID-19 patients’ lung problems. The aim of this study was to demonstrate the relationship between IL-6 levels and chest radiographs (Brixia score) that represent COVID-19 severity. A retrospective cohort study was conducted among COVID-19 patients who had a chest X-ray and examination of IL-6 levels at H. Adam Malik General Hospital, Medan, Indonesia. A multinomial logistic regression analysis was conducted to evaluate the association between IL-6 levels and the severity of the chest radiograph. A total of 76 COVID-19 patients were included in the study and 39.5% of them were 60–69 years old, with more than half were female (52.6%). A total of 17.1%, 48.7%, and 34.2% had IL-6 level of 50 pg/mL, respectively. There were 39.5%, 36.8% and 23.7% of the patients had mild, moderate and severe chest X-rays based on Brixia score, respectively. Statistics analysis revealed that moderate (OR: 1.77; 95% CI: 1.05–3.32) and severe (OR: 1.33; 95% CI: 1.03–3.35) lung conditions in the chest X-rays were significantly associated with IL-6 levels of 7–50 pg/mL. IL-6 more than 50 pg/mL was associated with severe chest X-ray condition (OR: 1.97; 95% CI: 1.15–3.34). In conclusion, high IL-6 levels significantly reflected COVID-19 severity through chest X-rays in COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
- Department of Pulmonology and Respiratory Medicine, Universitas Sumatera Utara General Hospital, Medan, Indonesia.
- Department of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
- Department of Radiology, Universitas Sumatera Utara General Hospital, Medan, Indonesia.
- Department of Community and Preventive Medicine, Faculty of Public Health, Universitas Sumatera Utara, Medan, Indonesia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.
Zitieren
APA
Kardiasyah, A., Syarani, F., Bihar, S., Lubis, N. D., Mutiara, E., & Syahputra, H. (2024). Relationship between interleukin-6 (IL-6) levels and chest X-ray severity scoring in COVID-19 patients. Narra J. https://doi.org/10.52225/narra.v4i1.690
Vancouver
Kardiasyah A, Syarani F, Bihar S, Lubis ND, Mutiara E, Syahputra H. Relationship between interleukin-6 (IL-6) levels and chest X-ray severity scoring in COVID-19 patients. Narra J. 2024. doi:10.52225/narra.v4i1.690
BibTeX
@article{Kardiasyah2024,
author = {Kardiasyah, Alzi and Syarani, Fajrinur and Bihar, Syamsul and Lubis, Netty D and Mutiara, Erna and Syahputra, Hafid},
title = {Relationship between interleukin-6 (IL-6) levels and chest X-ray severity scoring in COVID-19 patients},
journal = {Narra J},
year = {2024},
doi = {10.52225/narra.v4i1.690}
}
EUVIMED